223 related articles for article (PubMed ID: 31835852)
1. Structural and Dynamic Characterizations Highlight the Deleterious Role of SULT1A1 R213H Polymorphism in Substrate Binding.
Dash R; Ali MC; Dash N; Azad MAK; Hosen SMZ; Hannan MA; Moon IS
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835852
[TBL] [Abstract][Full Text] [Related]
2. Dimerization is responsible for the structural stability of human sulfotransferase 1A1.
Lu LY; Chiang HP; Chen WT; Yang YS
Drug Metab Dispos; 2009 May; 37(5):1083-8. PubMed ID: 19237513
[TBL] [Abstract][Full Text] [Related]
3. Carboxyl residues in the active site of human phenol sulfotransferase (SULT1A1).
Chen G; Rabjohn PA; York JL; Wooldridge C; Zhang D; Falany CN; Radominska-Pandya A
Biochemistry; 2000 Dec; 39(51):16000-7. PubMed ID: 11123927
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis for the broad substrate specificity of human sulfotransferase 1A1.
Berger I; Guttman C; Amar D; Zarivach R; Aharoni A
PLoS One; 2011; 6(11):e26794. PubMed ID: 22069470
[TBL] [Abstract][Full Text] [Related]
5. SULT1A1 R213H polymorphism and breast cancer risk: a meta-analysis based on 8,454 cases and 11,800 controls.
Wang Z; Fu Y; Tang C; Lu S; Chu WM
Breast Cancer Res Treat; 2010 Jul; 122(1):193-8. PubMed ID: 19949855
[TBL] [Abstract][Full Text] [Related]
6. Structure of a human carcinogen-converting enzyme, SULT1A1. Structural and kinetic implications of substrate inhibition.
Gamage NU; Duggleby RG; Barnett AC; Tresillian M; Latham CF; Liyou NE; McManus ME; Martin JL
J Biol Chem; 2003 Feb; 278(9):7655-62. PubMed ID: 12471039
[TBL] [Abstract][Full Text] [Related]
7. Insights into the substrate binding mechanism of SULT1A1 through molecular dynamics with excited normal modes simulations.
Dudas B; Toth D; Perahia D; Nicot AB; Balog E; Miteva MA
Sci Rep; 2021 Jun; 11(1):13129. PubMed ID: 34162941
[TBL] [Abstract][Full Text] [Related]
8. Lack of association of SULT1A1 R213H polymorphism with colorectal cancer: a meta-analysis.
Zhang C; Li JP; Lv GQ; Yu XM; Gu YL; Zhou P
PLoS One; 2011; 6(6):e19127. PubMed ID: 21695180
[TBL] [Abstract][Full Text] [Related]
9. Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation.
Nagar S; Walther S; Blanchard RL
Mol Pharmacol; 2006 Jun; 69(6):2084-92. PubMed ID: 16517757
[TBL] [Abstract][Full Text] [Related]
10. The structure of human SULT1A1 crystallized with estradiol. An insight into active site plasticity and substrate inhibition with multi-ring substrates.
Gamage NU; Tsvetanov S; Duggleby RG; McManus ME; Martin JL
J Biol Chem; 2005 Dec; 280(50):41482-6. PubMed ID: 16221673
[TBL] [Abstract][Full Text] [Related]
11. The potent inhibition of human cytosolic sulfotransferase 1A1 by 17α-ethinylestradiol is due to interactions with isoleucine 89 on loop 1.
Rohn-Glowacki KJ; Falany CN
Horm Mol Biol Clin Investig; 2014 Dec; 20(3):81-90. PubMed ID: 25418972
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of the sulfotransferase 1A1 and breast cancer risk.
Langsenlehner U; Krippl P; Renner W; Yazdani-Biuki B; Eder T; Wolf G; Wascher TC; Paulweber B; Weitzer W; Samonigg H
Breast Cancer Res Treat; 2004 Sep; 87(1):19-22. PubMed ID: 15377847
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of SULT1A2 and SULT1A1 *3: insights into the substrate inhibition and the role of Tyr149 in SULT1A2.
Lu J; Li H; Zhang J; Li M; Liu MY; An X; Liu MC; Chang W
Biochem Biophys Res Commun; 2010 May; 396(2):429-34. PubMed ID: 20417180
[TBL] [Abstract][Full Text] [Related]
14. Human cytosolic sulfotransferase SULT1A1.
Hempel N; Gamage N; Martin JL; McManus ME
Int J Biochem Cell Biol; 2007; 39(4):685-9. PubMed ID: 17110154
[TBL] [Abstract][Full Text] [Related]
15. Functional genetic variants in the 3'-untranslated region of sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity.
Yu X; Dhakal IB; Beggs M; Edavana VK; Williams S; Zhang X; Mercer K; Ning B; Lang NP; Kadlubar FF; Kadlubar S
Toxicol Sci; 2010 Dec; 118(2):391-403. PubMed ID: 20881232
[TBL] [Abstract][Full Text] [Related]
16. The structure of the catechin-binding site of human sulfotransferase 1A1.
Cook I; Wang T; Girvin M; Leyh TS
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14312-14317. PubMed ID: 27911811
[TBL] [Abstract][Full Text] [Related]
17. Association of human cytochrome P450 1A1 (CYP1A1) and sulfotransferase 1A1 (SULT1A1) polymorphisms with differential metabolism and cytotoxicity of aminoflavone.
Zheng Q; Sha X; Liu J; Heath E; Lorusso P; Li J
Mol Cancer Ther; 2010 Oct; 9(10):2803-13. PubMed ID: 20713530
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a conserved tryptophanyl residue in donor substrate binding and catalysis by a phenol sulfotransferase (SULT1A1).
Beckmann JD; Chodavarapu S; Doyle B
Arch Biochem Biophys; 2020 Nov; 695():108621. PubMed ID: 33049293
[TBL] [Abstract][Full Text] [Related]
19. Sulfotransferase 1A1 Substrate Selectivity: A Molecular Clamp Mechanism.
Cook I; Wang T; Leyh TS
Biochemistry; 2015 Oct; 54(39):6114-22. PubMed ID: 26340710
[TBL] [Abstract][Full Text] [Related]
20. Impact of polymorphism in sulfotransferase gene on the risk of lung cancer.
Pachouri SS; Sobti RC; Kaur P; Singh J; Gupta SK
Cancer Genet Cytogenet; 2006 Nov; 171(1):39-43. PubMed ID: 17074589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
